Jianing Cui1, Tao Li1, Xiuzheng Yue2, and Chuncai Luo1
1Radiology, the First Medical center, PLA General Hospital, Beijing, China, 2Philips Healthcare, Beijing, China
Synopsis
Keywords: Heart, MR Value, cardiac magnetic resonance-feature tracking
Early diagnosis of cardiac
amyloidosis (CA) and accurate assessment of cardiac function is important for CA
patients. LV strain
and strain rate obtained by cardiac magnetic resonance-featured tracking
(CMR-FT) have been developed as sensitive indicators of myocardial function. This
study aimed to evaluate myocardial
function in patients with CA by strain and strain rate to assess their
prognostic value in patients with CA. Our data showed that strain rate could be used to assess the degree of
cardiac impairment in CA and the difference with HCM providing prognostic information for all-cause mortality
in CA patients.
Introduction
Cardiac amyloidosis (CA) is a
form of restrictive cardiomyopathy due to abnormal amyloid deposition in the
heart 1. The diagnosis of CA should be difficult due to the presence
of left ventricular (LV) myocardial hypertrophy in both CA and hypertrophic
cardiomyopathy (HCM). Therefore, early diagnosis of CA and accurate assessment
of cardiac function are important for patients with CA2. Recently, LV
strain and strain rate obtained by cardiac magnetic resonance-featured tracking
(CMR-FT) have been developed as sensitive indicators of myocardial function. CMR-FT
has been used to assess myocardial function in patients with CA3. Until now, studies regarding relationship between myocardial strain rate and
all-cause mortality in patients with CA are lacking. This study aimed to evaluate myocardial function in patients
with CA and HCM by strain and strain rate, assessing their prognostic value in
patients with CA.Materials and Methods
Thirty-one
patients with CA (mean age: 54±11
years, 20 males) who underwent
CMR scanning on 1.5-T scanners(Multiva, Philips Healthcare, Netherlands) at our
hospital were retrospectively collected from March 2013 to June 2021. Comparisons
were made with 31 age and gender-matched patients with HCM (mean age: 55±12 years, 22 males) and 31 normal controls (NC) (mean age: 54±11 years, 20 males). Cardiac function was evaluated by balanced turbo field echo (BTFE)
cine sequence at the continuous short-axis covering the whole LV and the
long-axis (2/3/4 chamber) views under breath-holding. Imaging parameters
included TR/TE 3.7/1.8ms, in-plane resolution 1.4 × 1.4mm2, flip
angle 60° and slice thickness 8mm with 8 to 12 slices gathered on the
short-axis.
The parameters of
LV volumes and function were calculated using CVI42 (Circle Cardiovascular Imaging, Calgary, Canada), including LV end-diastolic
volume (LVEDV), LV end-systolic volume (LVESV), LV ejection fraction (LVEF), LV
systolic myocardial mass (LVSMM)、LV diastolic
myocardial mass(LVDMM), and cardiac output (CO). Radial, circumferential and
longitudinal strains and strain rates of LV at global and each myocardial
segment (basal, middle, and apical) were obtained with the CMR-FT technique,
and the differences in parameters among 3 groups were analyzed. Clinical
follow-ups were initiated from the CMR scan. The primary outcome was defined
as all-cause death. The predictive value of myocardial
strains and strain rates on all-cause mortality in CA patients was analyzed with
the stepwise COX regression model.Results
The
differences in left ventricular volume, myocardial mass, ejection fraction, and
cardiac output were statistically significant in all three groups (P
< 0.05). Except for the apical longitudinal strain, global and segmental
strains were significantly lower in the CA group than in the HCM group (P
< 0.05). The global and segmental strains were significantly lower in the CA
group than in the NC group (P < 0.05). The basal strain rates in
three directions were significantly lower in the CA group than in the NC group
(P< 0.05), but the difference in apical strain rates between the two
groups was not statistically significant. Multivariate stepwise COX analysis
showed that troponin T (HR = 1.05, 95% CI: 1.01-1.10, P = 0.017) and middle peak diastolic circumferential strain rate (HR = 6.87, 95% CI: 1.52-31.06, P =
0.012) were strong predictors of death.Discussion
In the present study, we found that the global and all segmental strain rates in three directions were significantly lower in the CA group compared with the NC group. The global and all segmental longitudinal strain rate were significantly lower in the HCM group compared with the NC group, indicating that myocardial function was reduced in both the CA and HCM groups. In addition, the basal strain rates in three directions were significantly lower in the CA group compared with the NC group, but the number of strain rates that were significantly different between the two groups gradually decreased from the base to the apex of LV, indicating that the severity of impaired myocardial function in the CA group gradually decreased from the base to the apex of LV. For the clinic, the prognosis of patients with CA is often a major concern. In our study, troponin T and middle peak diastolic circumferential strain rate were independent predictors of death even after adjustment for other parameters. A previous study reported that the contraction of subendocardial fibers of the myocardium contributes to longitudinal shortening, while the contraction of subepicardial fibers contributes to circumferential shortening, both of which lead to radial thickening4. Amyloid deposition tends to move from the endocardium to the epicardium 5, so decreased circumferential strain rate represents whole myocardial injury, suggesting a poor prognosis.Conclusions
Strain and strain rate parameters derived from CMR-FT based on cine sequences are new noninvasive imaging markers that can be used to assess the degree of cardiac impairment in CA and the difference in cardiac function with HCM providing independent prognostic information for all-cause mortality in CA patients.Acknowledgements
No acknowledegments in this abstract.References
[1]Esplin BL, Gertz MA. Current
trends in diagnosis and management of cardia camyloidosis[J]. Curr Probl
Cardiol, 2013;38(2):53-96.
[2] Wan K, Sun J, Yang D, et al.
Left Ventricular Myocardial Deformation on Cine MR Images: Relationship to Severity
of Disease and Prognosis in Light-Chain Amyloidosis[J]. Radiology.
2018;288(1):73-80.
[3]Jung HN, Kim SM, Lee JH, et
al. Comparison of tissue tracking assessment by cardiovascular magnetic
resonance for cardiac amyloidosis and hypertrophic cardiomyopathy. Acta Radiol.
2020 Jul;61:885-893.
[4]Claus P, Omar AMS, Pedrizzetti
G, et al. Tissue Tracking Technology for Assessing Cardiac Mechanics: Principles,
Normal Values, and Clinical Applications[J]. JACC Cardiovasc Imaging 2015;
8(12):1444–1460.
[5]Li R, Yang ZG, Xu HY, et al. Myocardial Deformation in
Cardiac Amyloid Light-chain Amyloidosis: Assessed with 3T Cardiovascular
Magnetic Resonance Feature Tracking[J]. Sci Rep. 2017;7(1):3794. Published
2017 Jun 19.